Neovacs S.A. (ALNEV.PA)
Develops therapeutic vaccines using Kinoid technology to treat autoimmune diseases and allergies.
0.78+0.05%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-100.0%
The outlook
Neovacs (ALNEV.PA) is trading near its 52-week lows with minimal upward movement today. The stock sits well below both its 50- and 200-day moving averages, signaling a weak near-term trend. Analyst coverage appears limited, and the overall sentiment reflected in available data leans bearish.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$36
52-wk high
14,500.00
52-wk low
0.70
50-day avg
1.72
200-day avg
83.17
Trailing P/E
—